PLX3397 (Pexidartinib)
|
|
- CAS-Nr.
- 1029044-16-3
- Englisch Name:
- PLX3397 (Pexidartinib)
- Synonyma:
- Pexidartinib;Turalio;PLX-3397;Pexidartinib (PLX3397);[5-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-pyridin-2-yl]-(6-trifluoromethyl-pyridin-3-ylmethyl)-amine;PLX339;CML261;FP113);CS-1695;Peridartinib
- CBNumber:
- CB22742977
- Summenformel:
- C20H15ClF3N5
- Molgewicht:
- 417.81
- MOL-Datei:
- 1029044-16-3.mol
|
PLX3397 (Pexidartinib) Eigenschaften
- Dichte
- 1.458±0.06 g/cm3(Predicted)
- storage temp.
- -20°C
- L?slichkeit
- Soluble in DMSO (up to at least 10 mg/ml)
- pka
- 12.81±0.40(Predicted)
- Aggregatzustand
- solid
- Farbe
- White
- Stabilit?t:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months.
- CAS Datenbank
- 1029044-16-3
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P302+P352, P321,P332+P313, P362 |
H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizit?t (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
|
|
Sicherheit |
P261 |
Einatmen von Staub vermeiden. |
P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
|
PLX3397 (Pexidartinib) Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Colony stimulating factor 1 (CSF1) is a cytokine that is involved in the recruitment and activation of tissue macrophages. It exerts these effects by binding to its corresponding receptor tyrosine kinase, the cFMS/CSF1 receptor (CSF1R). Pexidartinib is a brain-penetrant inhibitor of CSF1R, as well as c-Kit and FLT3 (IC
50s = 20, 10, and 160 nM
in vitro, respectively). It has been used in combination with paclitaxel to block macrophage recruitment in mammary tumor-bearing mice, thus slowing primary tumor development and metastasis. Pexidartinib has also been used to block microglial stimulation of glioblastoma invasion in both cell culture and a mouse model of glioblastoma multiforme.
Verwenden
Pexidartinib is RTK inhibitor. It can be used in pharmacological activity, therapeutic use, and biological study of inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition.
Trademarks
Turalio
PLX3397 (Pexidartinib) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
PLX3397 (Pexidartinib) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 157)Lieferanten
1029044-16-3()Verwandte Suche:
- 5-((5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)-N-((6-(trifluoromethyl)pyridin-3-yl)methyl)
- 3-Pyridinemethanamine,N-[5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-6-(trifluoromethyl)-
- N-[5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-6-(trifluoromethyl)-3-pyridinemethanamine
- PLX3397 (Pexidartinib)
- PLX339
- 5-((5-chloro-1H-pyrrolo[2,3-b]pyridin-2-yl)methyl)-N-((6-(trifluoromethyl)pyridin-3-yl)methyl)pyridin-2-amine
- 5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)pyridin-3-yl]methyl]pyridin-2-amine
- CS-1695
- PLX3397;PLX 3397;PLX-3397
- PLX3397 (Pexidartinib) USP/EP/BP
- Peridartinib
- CML261
- FP113)
- PLX-3397
- Pexidartinib (PLX3397)
- Pexidartinib
- [5-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-pyridin-2-yl]-(6-trifluoromethyl-pyridin-3-ylmethyl)-amine
- Turalio
- 13C,2H4]-Peridartinib
- PLX3397,inhibit,PLX 3397,CSF-1 receptor,SCFR,Pexidartinib,Inhibitor,c-Fms,Apoptosis,CSF-1R,colony stimulating factor 1 receptor,CSF1R,CD117,c-Kit
- 5-[[5-Chloropyrrolo[2,3-b]pyridin-3-yl]methyl]-2-[[[6-(trifluoromethyl)-3-pyridyl]methyl]amino]pyridine
- Morinidazole Impurity 14
- 1-(5-methyl-2-nitro-1H-imidazol-1-yl)-3-morpholinopropan-2-ol
- 1029044-16-3
- 1029004-16-3
- C20H15ClF3N5
- Inhibitors
- API